The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
78922316 7892231 6 F 2004 20160721 20110408 20160725 EXP US-009507513-1103USA03954 MERCK 0.00 F Y 58.51000 KG 20160725 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
78922316 7892231 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
78922316 7892231 2 SS FOSAMAX PLUS D ALENDRONATE SODIUMCHOLECALCIFEROL 1 Oral 70 MG, QW 0 70 MG TABLET /wk
78922316 7892231 3 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, UNK 20560 70 MG TABLET
78922316 7892231 4 C CALCIUM (UNSPECIFIED) CALCIUM 1 600 MG, BID U 0 600 MG TABLET BID
78922316 7892231 5 C VITAMIN D CHOLECALCIFEROL 1 400 IU, QD U 0 400 IU CAPSULE QD
78922316 7892231 6 C BONIVA IBANDRONATE SODIUM 1 150 MG, QM 0 150 MG TABLET /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
78922316 7892231 1 Osteoporosis
78922316 7892231 2 Osteoporosis
78922316 7892231 3 Osteoporosis
78922316 7892231 4 Osteoporosis
78922316 7892231 5 Osteoporosis
78922316 7892231 6 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
78922316 7892231 DS
78922316 7892231 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
78922316 7892231 Adverse drug reaction
78922316 7892231 Arthralgia
78922316 7892231 Arthropathy
78922316 7892231 Back pain
78922316 7892231 Cystitis
78922316 7892231 Drug hypersensitivity
78922316 7892231 Dysaesthesia
78922316 7892231 Essential hypertension
78922316 7892231 Fall
78922316 7892231 Femur fracture
78922316 7892231 Foot deformity
78922316 7892231 Haematuria
78922316 7892231 Hyperkeratosis
78922316 7892231 Hypertrophy
78922316 7892231 Intervertebral disc degeneration
78922316 7892231 Intervertebral disc protrusion
78922316 7892231 Intervertebral disc space narrowing
78922316 7892231 Lumbar radiculopathy
78922316 7892231 Lumbar spinal stenosis
78922316 7892231 Muscular weakness
78922316 7892231 Musculoskeletal disorder
78922316 7892231 Nausea
78922316 7892231 Neoplasm
78922316 7892231 Nephrolithiasis
78922316 7892231 Oedema peripheral
78922316 7892231 Onychomycosis
78922316 7892231 Pain in extremity
78922316 7892231 Paraesthesia
78922316 7892231 Peroneal nerve palsy
78922316 7892231 Radius fracture
78922316 7892231 Scar
78922316 7892231 Spinal compression fracture
78922316 7892231 Spinal osteoarthritis
78922316 7892231 Tendon disorder
78922316 7892231 Urinary tract infection
78922316 7892231 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
78922316 7892231 1 200109 20100901 0
78922316 7892231 2 200109 201009 0
78922316 7892231 3 20080721 20100818 0
78922316 7892231 6 20080925 0